Axial Stability in Short and Long Eyes After Cataract Surgery
NCT ID: NCT07210372
Last Updated: 2025-10-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
34 participants
OBSERVATIONAL
2023-12-04
2025-01-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Positional Stability and Refractive Behaviour After Implantation of an IOL After Cataract Surgery
NCT06069752
Evaluation of Axial Stability of Two Models of Intraocular Lenses in Patients With an Eye Length More Than 26 mm
NCT05129566
Rotational Stability of Different Intraocular Lenses in The Capsular Bag
NCT03761745
Visual Performance of Bilateral AcrySof ReSTOR Aspheric +4
NCT01215045
Anterior Chamber Depth Variability Between Two Lenses With Different Materials
NCT03751215
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypothesis: Implantation of the Clareon IOL leads to a stable post-operative IOL position in short (≤22.75mm) and long (≥25.50mm) eyes.
Endpoints:
Primary Endpoint: change in anterior chamber depth (=IOL position) in mm from 1 week to 12 weeks post-operative visit for both short and long eyes (two separate analysis) (Refraction will be a secondary outcome due to its larger variability compared to ACD measurements 1)
Secondary Endpoint:
* Refractive outcome after Clareon IOL implantation at 1- and 12-week visit o
* Monocular BCDVA and DCIVA (66cm) at 1 week and 12-week post-operative visit
o Subjects with a post operative tilt (at 12-week post operative visit) ≥10⁰ will be excluded from VA analysis
* Change in ACD in mm from 1 hour to 12 weeks, 1 hour to 1-week post-op visit for both short and long eyes Exploratory Endpoints
* Comparison of refractive outcome between long and short eyes via prediction error for Barret Universal II for long eyes and Kane formula for short eyes with target emmetropia to -2.50D based on subject's visual needs ACD in mm 1 hour, 1 week, and 12 weeks post op as measured from corneal epithelium to anterior lens surface by IOL master 700, Casia II, and MS 39
Principal Objective: Aim of this study is to measure the change in the post-operative Anterior Chamber Depth of the Clareon monofocal IOL in short/long eyed patients at different post operative time points (1 hour, 1 week, and 12 weeks) during uneventful FLACS cataract surgery.
* Exploratory/secondary Objectives:
* To measure post-operative monocular corrected visual acuity of the Clareon IOL at distance and intermediate vision (66cm)
* To Compare refractive outcomes between long and short eyes
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
short eye
patients with eye length up to 22,75mm
No interventions assigned to this group
long eye
patients with eye length at least 25,50mm
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* axial eye length below 22,75mm or above 25.50mm
Exclusion Criteria
* pregnancy
* preoperative visual acuity above 1.0logMar
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Johannes Kepler University of Linz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nino Hirnschall, MD
Role: PRINCIPAL_INVESTIGATOR
Kepler Universitätsklinikum /JKU
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kepler University Clinic, Linz
Linz, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JKU-Ophthalmology-002-ACDC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.